InProTher secured DKK 10M in investment from Novo Nordisk Foundation.
15 February 2019
15 February 2019
Total investments received (USD): 6.95m
Round value (USD): 1.52m
Round investors:
Novo A/S
Company: InProTher
Industry:
Biotech
Health services
Related deals
RetiPharma completed a EUR 1,3M capital funding round from the Novo Nordisk Foundation’s BioInnovation Institute.
Investments
12 November 2018
Belgium
Netherlands
Austria
Germany
Switzerland
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
France
Ireland
Italy
Portugal
Spain
United Kingdom